Quantcast

Latest Personalized medicine Stories

2014-04-02 20:22:25

DUBLIN, April 3, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/fz82h5/biomarkers ) has announced the addition of the "Biomarkers: Discovery Techniques and Applications - A Global Market Overview" [http://www.researchandmarkets.com/research/fz82h5/biomarkers ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The potential offered by biomarkers in shaping the outcomes of clinical trials,...

2014-04-01 08:28:14

ConvergeHEALTH, M2Gen and Deloitte will offer personalized medicine studies and real-world analytics services to life sciences organizations, study sponsors and cancer centers NEW YORK, April 1, 2014 /PRNewswire/ -- ConvergeHEALTH by Deloitte is announcing that M2Gen, a wholly-owned subsidiary of Moffitt Cancer Center, has joined its real-world evidence and analytics consortium to help transform cancer care around the use of personalized medicine....

2014-03-31 08:30:19

DALLAS, March 31, 2014 /PRNewswire/ -- According to a new market research report "Proteomics Market by Technology (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) Instruments, Reagents & Services - Global Forecast to 2018", published by MarketsandMarkets, The market was valued at $10,223.0 Million in 2013 and is expected to grow at a healthy CAGR from 2013 to 2018. Browse 138...

2014-03-28 12:26:41

Tute launches automated clinical reporting for CLIA-certified genetics labs at ACMG, enabling Genome-guided Personalized Medicine PROVO, Utah, March 28, 2014 /PRNewswire-iReach/ -- Tute Genomics has been selected as the next-generation sequencing (NGS) analytics pipeline for Utah-based Affiliated Genetics, Inc (AGI). AGI performs a wide variety of diagnostic services, including pharmacogenetic testing, and CLIA-certified sequencing of gene panels and whole exomes for clinicians and...

2014-03-28 08:26:18

IRVING, Texas, March 28, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, continues to enhance its industry-leading comprehensive tumor profiling service, Caris Molecular Intelligence(TM), now capable of providing an industry-leading 51 drug target associations, including exciting new immunologically-based drug targets. Through these enhancements, Caris Molecular Intelligence will now provide...

2014-03-27 23:04:36

This report broadly categorizes the global gene expression analysis market into three segments, namely, instrumentation, consumables, and services. http://www.marketsandmarkets.com/Market-Reports/gene-expression-analysis-market-156613968.html (PRWEB) March 27, 2014 According to the new market research report, “Gene Expression Analysis Market by Technology (DNA Microarray, Real-Time PCR, Next Generation Sequencing), Consumables (DNA Chips, Reagents), Services (Gene Profiling,...

2014-03-25 23:21:36

New integrated desktop system provides access to Bina’s accurate, scalable and easy-to-use genomic data analysis tools without the need for an IT team Redwood City, CA (PRWEB) March 25, 2014 Bina Technologies, the standard for high-performance genomic analysis, today introduced Bina Desktop, a brand new deployment of its genomic analysis platform, Bina Analytics. Designed especially for clinical and academic researchers, Bina Desktop analyzes large, complex Next-Generation Sequencing...

2014-03-25 08:30:12

- Effort designed to help revolutionize access to genomic interpretation services in hospitals, molecular diagnostics companies and academic medical centers throughout the U.S. - ROCKVILLE and BALTIMORE, Md., March 25, 2014 /PRNewswire/ -- Strand Genomics Inc. (Strand) and BioHealth Innovation, Inc. (BHI) today announced a strategic partnership designed to expand the Strand Centers for Genomics & Personalized Medicine into the U.S. This effort is intended to help revolutionize...

2014-03-24 23:27:51

Lead Candidate Provides Targeted and Personalized Medicine Approach to Lung Cancer Somerville, MA (PRWEB) March 24, 2014 ANDARIX Pharmaceuticals, a leader in the discovery and development of targeted peptide therapy for lung and neuroendocrine cancer announced today that P2045, the Company's lead candidate for targeted peptide therapy, has been granted Orphan Drug Designation by the U.S. Food & Drug Administration (FDA) for the treatment of small cell lung cancer (SCLC). Orphan...

2014-03-25 00:23:11

DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/tp3h3r/global_imaging) has announced the addition of the "Global Imaging Biomarkers Market 2014-2018" [http://www.researchandmarkets.com/research/tp3h3r/global_imaging ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The analysts forecast the Global Imaging Biomarkers market to grow at a CAGR of 15.09 percent over the...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.